Showing 1 - 17 results of 17 for search 'Françoise Kraeber-Bodere', query time: 0.06s
Refine Results
-
1
[18F]-Fludarabine for Hematological Malignancies by Louisa Barré, Narinée Hovhannisyan, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Gandhi Damaj
Published 2019-04-01
Article -
2
Reply to E. Laffon et al. by Clément Bailly, Thomas Carlier, Françoise Kraeber-Bodéré, Steven Le Gouill, Caroline Bodet-Milin
Published 2020-01-01
Article -
3
Immuno-PET: Design options and clinical proof-of-concept by Alexandre Lugat, Clément Bailly, Clément Bailly, Michel Chérel, Michel Chérel, Caroline Rousseau, Caroline Rousseau, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2022-10-01
Article -
4
-
5
-
6
-
7
Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma. by Clement Bailly, Rodolphe Leforestier, Loic Campion, Estelle Thebaud, Anne Moreau, Francoise Kraeber-Bodere, Thomas Carlier, Caroline Bodet-Milin
Published 2017-01-01
Article -
8
Potential for Nuclear Medicine Therapy for Glioblastoma Treatment by Clément Bailly, Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2019-07-01
Article -
9
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial by Caroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, Gauthier Frecon, Olivier Tournilhac, Violaine Safar, Françoise Kraeber-Bodere, Steven Le Gouill, Elizabeth Macintyre, Clément Bailly
Published 2023-10-01
Article -
10
-
11
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET... by Bastien Jamet, Hatem Necib, Thomas Carlier, Eric Frampas, Juliette Bazin, Paul-Henri Desfontis, Aurélien Monnet, Caroline Bodet-Milin, Philippe Moreau, Cyrille Touzeau, Francoise Kraeber-Bodere
Published 2024-07-01
Article -
12
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin’s lymphoma by 18F-fluorodeoxyglucose positron emission tomography by Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Benoît Dupas, Franck Morschhauser, Thomas Gastinne, Steven Le Gouill, Loïc Campion, Jean-Luc Harousseau, William A. Wegener, David M. Goldenberg, Damien Huglo
Published 2008-03-01
Article -
13
Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients by Christelle Darrieutort-Laffite, Catherine Ansquer, Hélène Aubert, Françoise Kraeber-Bodéré, Agathe Masseau, Christian Agard, Mohamed Hamidou, Claire Bernier, Jean-Marie Berthelot, Benoit Le Goff, Sébastien Barbarot, Antoine Néel
Published 2020-11-01
Article -
14
Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases by Baptiste Pichon, Caroline Rousseau, Audrey Blanc-Lapierre, Gregory Delpon, Ludovic Ferrer, Vincent Libois, Matthieu Le Turnier, Cédric Lenoble, Caroline Bodet-Milin, David M. Goldenberg, Françoise Kraeber-Bodere, Stéphane Supiot
Published 2020-11-01
Article -
15
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project by Clément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, Olivier Casasnovas, Emmanuel Gyan, Michel Meignan, Anne Moreau, Barbara Burroni, Loïc Djaileb, Remy Gressin, Anne Devillers, Thierry Lamy, Catherine Thieblemont, Olivier Hermine, Françoise Kraeber-Bodéré, Steven Le Gouill, Caroline Bodet-Milin
Published 2020-01-01
Article -
16
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation by Baptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, Bastien Jamet, Céline Bossard, Benoit Tessoulin, Thomas Gastinne, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Chloé Antier, Olivier Theisen, Françoise Kraeber‐Bodéré, Steven Le Gouill, Marie C. Béné, Philippe Moreau, Cyrille Touzeau
Published 2020-07-01
Article -
17
Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study by Françoise Kraeber-Bodéré, Sonja Zweegman, Aurore Perrot, Cyrille Hulin, Denis Caillot, Thierry Facon, Xavier Leleu, Karim Belhadj, Emmanuel Itti, Lionel Karlin, Clément Bailly, Mark-David Levin, Monique C. Minnema, Bastien Jamet, Caroline Bodet-Milin, Bart de Keizer, Marie C. Béné, Hervé Avet-Loiseau, Pieter Sonneveld, Lixia Pei, Fabio Rigat, Carla de Boer, Jessica Vermeulen, Tobias Kampfenkel, Jérôme Lambert, Philippe Moreau
Published 2022-10-01
Article